Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells

Journal of Virology

Volumn 72, Issue 7, 1998, Pages 5781-5788

  Sutton, Richard E ^a,c   Wu, Henry T M ^a   Rigg, Richard ^b   Böhnlein, Ernst ^b   Brown, Patrick O ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CLONOGENIC ASSAY; EXPRESSION VECTOR; GENE DELETION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; VIRUS REPLICATION;

EID: 0031747965     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.7.5781-5788.1998     Document Type: Article

References (47)

1. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70:2581-2585.
2. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666-669.
3. Chatterjee, S., D. Lu, G. Podsakoff, and K. K. Wong. 1995. Strategies for efficient gene transfer into hematopoietic cells: the use of adeno-associated virus vectors in gene therapy. Ann. N. Y. Acad. Sci. 770:79-90.
4. Chun, T.-W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. M. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
5. Corbeau, P., G. Kraus, and F. Wong-Stall. 1996. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc. Natl. Acad. Sci. USA 93:14070-14075.
6. Cournoyer, D., and C. T. Caskey. 1993. Gene therapy of the immune system. Annu. Rev. Immunol. 11:297-329.
7. Dunbar, C. E., and R. V. Emmons. 1994. Gene transfer into hematopoietic progenitor and stem cells: progress and problems. Stem Cells 12:563-576.
8. Forestell, S. P., E. Bohnlein, and R. J. Rigg. 1995. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther. 2:723-730.
9. Gallay, P., V. Stitt, C. Mundy, M. Oettinger, and D. Trono. 1996. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1027-1032.
10. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of non-dividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
11. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of Matrix to the core domain of integrase. Cell 83:569-575.
12. Gilboa, E. 1990. Retroviral gene transfer: applications to human therapy. Prog. Clin. Biol. Res. 352:301-311.
13. Goodman, S., X. Xiao, R. E. Donahue, A. Moulton, J. Miller, C. Walsh, N. S. Young, R. J. Samulski, and A. W. Nienhuis. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500.
14. 2 activity. J. Virol. 69:6705-6711.
15. He, J., and N. R. Landau. 1995. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor. J. Virol. 69:4587-4592.
16. Heinzinger, N. K., M. I. Bukinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
17. 2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
18. Kishi, M., Y. Nishino, M. Sumiya, K. Ohki, T. Kimura, I. Goto, M. Nakai, M. Kakinuma, and K. Ikuta. 1992. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. J. Gen. Virol. 73:77-87.
19. Kishi, M., Y.-H. Zheng, M. K. Bahmani, K. Tokunaga, H. Takahashi, M. Kakinuma, P. K. Lai, M. Nonoyama, R. B. Luftig, and K. Ikuta. 1995. Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. J. Virol. 69:7507-7518.
20. Kohn, D. B. 1995. The current status of gene therapy using hematopoietic stem cells. Curr. Opin. Pediatr. 7:56-63.
21. Kohn, D. B. 1997. Gene therapy for hematopoietic and lymphoid disorders. Clin. Exp. Immunol. 107:54-57.
22. Leavitt, A. D., G. Robles, N. Alesandro, and H. E. Varmus, 1996. Human immunodeficiency virus rype 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 70:721-728.
23. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses hut not for the human immunodeficiency virus. J. Virol. 68:510-516.
24. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431.
25. Marzio, P., S. Choe, M. Ebright, R. Knoblauch, and N. R. Landau. 1995. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficicncy virus type 1 Vpr. J. Virol. 69:7909-7916.
26. Mitani, K., P. R. Clemens, A. B. Moseley, and C. T. Caskey. 1993. Gene transfer therapy for heritable disease: cell and expression targeting. Philos. Trans. R. Soc. London Ser. B 339:217-224.
27. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
28. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
29. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
30. Neering, S. J., S. F. Hardy, D. Minamoto, S. K. Spratt, and C. T. Jordan. 1996. Transduction of primitive human hematopoeitic cells with recombinant adenovirus vectors. Blood 88:1147-1155.
31. Poeschla, E., P. Corbeau, and F. Wong-Staal. 1996. Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. USA 93:11395-11399.
32. Purvis, S. F., J. W. Jacobberger, R. M. Sramkoski, A. H. Patki, and M. M. Lederman. 1995. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retroviruses 11:443-450.
33. cdc2-cyclin B. J. Virol. 69:6859-6864.
34. Reiser, J., G. Harmison, S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
35. Roe, T., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
36. Sakai, K., X. Ma, I. Gordienko, and D. J. Volsky. 1991. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. J. Virol. 65:5765-5773.
37. Sasaki, D. T., E. H. Tichenar, F. Lopez, J. Combs, N. Uchida, C. R. Smith, W. Stokdijk, M. Vardanega, A. M. Buckle, and B. Chen. 1995. Development of a clinically applicable high-speed flow cytometer for the isolation of transplantable human hematopoeitic stem cells. J. Hematother. 4:503-514.
38. Schuitemaker, H., N. A. Kootstra, R. A. M. Fouchier, B. Hooibrink, and F. Miedema. 1994. Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity. EMBO J. 13:5929-5936.
39. Spina, C. A., J. C. Guatelli, and D. D. Richman. 1995. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69:2977-2988.
40. Sutton, R. E., and D. R. Littman. 1996. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70:7322-7326.
41. + T cells are infectable by human immunodeficiency virus but do not release virus after activation. J. Virol. 69:5659-5665.
42. Uchida, N., Z. Yang, J. Combs, O. Pourquie, M. Nguyen, R. Ramanathan, J. Fu, A. Welply, S. Chen, G. Weddell, et al. 1997. The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells. Blood 89:2706-2716.
43. von Schwedler, U., R. S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes Proc. Natl. Acad. Sci. USA 91:6992-6996.
44. Von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
45. Watanabe, T., C. Kuszynski, K. Ino, D. G. Heimann, H. M. Shephard, Y. Yasui, D. C. Maneval, and J. E. Talmadge. 1996. Gene transfer into human bone marrow hematopoeitic cells mediated by adenovirus vectors. Blood 87:5032-5039.
46. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500.
47. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.